Clinical trial

Rituximab-Induced Hypogammaglobulinemia in Multiple Sclerosis

NCT04283747

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2020-02-28

PhaseN/A

Study timeline

Study start (actual)2020-02-28Date precision: day

Registry last updated2020-07-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Multiple Sclerosisunresolved

Hypogammaglobulinemiaunresolved

Interventions

Serum immunoglobulin titerDIAGNOSTIC_TEST

Sponsors & collaborators

Mazandaran University of Medical Scienceslead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04283747 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.